Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(1)
•••
Comment by ConnectTheDot1on May 24, 2018 1:26pm
58 Views
Post# 28076241

RE:“We continue to see a strong demand in Canada for CBD produc

RE:“We continue to see a strong demand in Canada for CBD producInteresting comments...from another CEO as the one of Liberty George Scorsis explaining the reason that Liberty invested in ISODIOL: " Liberty Health Sciences is also looking ahead to a growing market sector: CBD products. The company made an investment in CBD company Isodiol International to prepare for growing demand of CBD consumer goods with medical and well-being applications, which could be facilitated by the proposed Hemp Farming Act of 2018. " https://www.newcannabisventures.com/liberty-health-sciences-aims-for-20-market-share-in-florida-and-continue-u-s-expansion/
wallstreetfun wrote:
“We continue to see a strong demand in Canada for CBD products and we are pleased to add another key supply agreement with a leading pharmaceutical grade consumer product manufacturer,” said Sundial CEO, Torsten Kuenzlen. “We will look forward to formulating additional products with both pharmaceutical and nutraceutical grade CBD isolate provided by Isodiol.”  https://finance.yahoo.com/news/isodiol-international-inc-announces-letter-120000350.html 
 
$ISOLF $ISOL 


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities